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Potassium and Hypertension 
A recent meta-analysis supports the premise that 
increased potassium intake may play a role in the 
prevention and treatment of hypertension. The 
possible mechanisms by which potassium may act 
as an antihypertensive and recommendations re- 
garding increasing potassium intake are also dis- 
cussed. 
High blood pressure represents one of the major modifi- 
able risk factors for coronary heart disease, congestive 
heart failure, stroke, and renal disease. Approximately 20% 
of the U.S. adult population has hypertension, which is 
defined as systolic blood pressure >I40 mm Hg and/or 
diastolic blood pressure > 90 mm Hg. The prevalence of 
hypertension varies strongly within and between popula- 
tions, and there is a profound increase in prevalence rates 
with increasing age. 
The differences in prevalence rates betwe& certain 
population groups and age groups may be due, in part, to 
differences in the occurrence of overweight, alcohol con- 
sumption, salt intake, physical activity, smoking, and other 
potentially modifiable risk factors.’ The modification of 
these risk factors represents the cornerstone of any 
nonphannacologic strategy of blood pressure control. 
The importance of electrolytes in the pathogenesis of 
hypertension is well known from the blood pressure-low- 
ering effect of salt restriction observed in salt-sensitive 
individuals. There is a strong interrelationship and inter- 
dependence between the electrolytes potassium and so- 
dium in the body. Accordingly, it is not surprising that 
many epidemiologic and intervention studies have re- 
ported a blood pressurelowering effect of potassium. 
Recently, Whelton et al? performed a meta-analysis 
of 33 randomized controlled clinical trials to assess the 
effects of oral potassium supplements on blood pressure. 
These studies included about 2600 subjects (age range 
18-79 years), and the potassium supplementation was the 
only difference between the intervention groups and con- 
trol groups. Potassium supplementation was associated 
with a significant reduction in mean (95% confidence in- 
terval) systolic and diastolic blood pressure of 3.1 1 mm 
Hg( 1.91 to4.31 mmHg)and 1.97mmHg(0.52to3.42mm 
Hg), respectively. These blood pressurelowering effects 
of potassium were especially pronounced in subjects with 
a high sodium intake. These effects were observed in both 
subjects who did and subjects who did not take antihy- 
pertensive medication. The conclusion of Whelton et aLZ 
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is in agreement with other recent publications on this is- 
sue, suggesting that low potassium intake may play an 
important role in the pathogenesis of hypertension and 
that increased potassium intake should be considered as 
a part of treatment of essential hypertension. 
In view of this confirmatory meta-analysis on the ef- 
fect of potassium on blood pressure, several important 
questions need to be addressed. What is the potential 
mechanism of potassium’s effect on blood pressure? Who 
can benefit most from increased potassium intake? Should 
physicians prescribe potassium supplements to patients? 
Are potassium supplements safe? How can we improve 
dietary intake of potassium from foods? Detailed discus- 
sion of all of these issues is beyond the scope of this 
review, but some important aspects of the metabolic pro- 
cesses that may explain the role of potassium in blood 
pressure regulation will be addressed. 
It is not known by which mechanism potassium af- 
fects blood pressure. Because of the heterogeneity of 
potassium’s effects on different cell and body functions, 
the blood pressure-lowering effects seem to be the result 
of several different mechanisms. These include effects on 
natriuresis, baroreflex sensitivity, direct vasodilatatory 
functions, catecholaminergic functions, and the central 
nervous system, as well as improvement of glucose toler- 
ance and modulation of the renin-angiotensin-aldoster- 
one ~ys t em.~ ,~  
As demonstrated in earlier studies, subjects in the 
Whelton et a1.2 study with a high sodium intake seemed to 
have the greatest potential for experiencing blood pres- 
surelowering effects of potassium. Several epidemiologic 
studies have described an inverse relationship between 
potassium intake and blood pressure and a direct relation- 
ship between the urinary sodidpotassium ratio and blood 
pressure. Increased potassium intake is associated with a 
natriuretic effect and may have a diuretic effect as well. 
Potassium depletion enhances the urinary loss of calcium, 
which is another important cation in the regulation of blood 
pressure? The increased loss of calcium in this situation 
may further stimulate parathyroid hormone secretion, 
which may additionally contribute to an increase in blood 
pressure. These effects are mediated by the renin-angio- 
tensin-aldosterone system. Potassium depletion leads to 
increased plasma renin activity via effects on the renal 
receptors and macula densa. Plasma renin activity can be 
lowered in most cases by the administration ofpotassium. 
Some studies reported a decline in blood pressure ofmore 
than 10 mm Hg upon potassium ~upplementation;~.’ how- 
ever, others found no significant e f f e ~ t . ~ . ~  
The lack of a blood pressure-lowering effect of po- 
tassium may be explained by a low-sodium diet, since a 
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low sodium delivery to the distal nephron hardly affects 
potassium secretion and, thus, loss in the urine. Further- 
more, in the case of a large natriuretic effect of a higher 
potassium intake, a lower plasma volume may result, lead- 
ing to a stimulation of plasma renin activity, which then 
abolishes the favorable blood pressure effects of potas- 
sium. 
The so-called baroreceptors are stretch receptors lo- 
cated in some large arteries. Potassium has been reported 
to influence baroreceptor sensitivity fa~orably.~ In addi- 
tion, potassium may function as a direct modulator of vas- 
cular resistance via its action as a vasodilatator. The 
vasodilatatory effects of potassium also seem to be of 
importance in exercise-induced blood pressure changes. 
During exercise, potassium is released from muscle cells, 
leading to an increase in extracellular potassium concen- 
tration, which induces a vasodilatation that increases lo- 
cal blood flow. Peripheral resistance, and thus blood pres- 
sure, may be influenced profoundly. Another action that 
is dependent on the concentration of potassium and so- 
dium is the uptake of catecholamines fro$ the synaptic 
cleft. Animal experiments have shown the pressor response 
to catecholamines could be partially blunted by pretreat- 
ment with potassium. 
Glucose intolerance, another important risk factor for 
cardiovascular disease, is a well-known feature of potas- 
sium depletion, and it is hypothesized that the disadvan- 
tageous effects of potassium-wasting diuretics on glu- 
cose metabolism may be mediated by hypokalemia. Ac- 
cordingly, it is possible that minor changes in potassium 
balance and status may induce changes in glucose toler- 
ance that lead to changes in blood pressure. It is probably 
the interplay of all of these mechanisms by which potas- 
sium causes a reduction in blood pressure. 
Potassium may have many other cardioprotective ef- 
fects, ranging from inhibition of free radical formation to 
an effect on platelet aggregati~n.~ Increased potassium 
concentrations reduce free radical production at the level 
of the endothelial cell, leading to a favorable blood pres- 
sure effect. The inhibitory effects of potassium on vascu- 
lar smooth muscle cell proliferation may have further pro- 
tective effects on the development of high blood pres- 
sure. These are just a few selected effects of the many 
important hc t ions  of potassium. Other effects include 
interrelationships between potassium and magnesium and 
insulin.I0 Magnesium seems to play an important role in 
the maintenance of different cardiovascular functions. In 
magnesium deficiency, potassium wasting occurs in the 
kidneys. High insulin levels enhance sodium reabsorp- 
tion and stimulate the sympathetic nervous system. 
Clinical experience suggests that the higher the blood 
pressure, the higher the benefit of any therapeutic inter- 
vention. Subjects with mild to moderate hypertension may 
benefit most from nonpharmacologic means of blood pres- 
sure control. Some studies have suggested a more pro- 
nounced effect of potassium on blood pressure in African 
Americans. In the meta-analysis of Whelton et al.,Z the 
race-related effects of potassium on blood pressure are 
less clear and less pronounced owing to the ecologic na- 
ture of the analysis and the limited information about the 
racial origin of the participants in some of the studies. 
Nevertheless, it has been suggested that in some popula- 
tion subgroups, such as African Americans, potassium 
intake may be even more crucial for blood pressure con- 
trol than sodium.2J0 Furthermore, the benefit seems to be 
greatest in subjects with borderline hypertension and a 
positive family history of hypertension. 
It is important to note that a high-potassium diet not 
only should be implemented after the development of hy- 
pertension, but also can be beneficial in the normotensive 
state, and should be a must in the high-normal range of 
blood pressure. In addition, as with any other strategy for 
blood pressure control, high potassium intake should oc- 
cur over a prolonged period of time, presuming there is 
normal kidney function. The intake of certain antihyper- 
tensive medications does not preclude an individual from 
consuming a high-potassium diet as well. 
It is generally not necessary to prescribe potassium 
supplements, except in the clinical setting of hypokale- 
mia. Because potassium supplements may have severe 
adverse effects, over-the-counter potassium supplements 
are not recommended for the general public. A careful pro- 
motion of potassium-containing salt-replacement season- 
ings could be useful; however, the composition of the 
electrolyte content in different commercial products is 
highly variable. Carefully reading food labels is very im- 
portant, because some products contain considerable 
amounts of sodium, which would counteract the effects 
of potassium. 
Although we do not yet know the physiology of the 
interaction between the different electrolytes and their 
effects on different aspects of the cardiovascular system, 
it is probably acceptable to promote a diet high in potas- 
sium. The average potassium intake in the United States 
varies widely between 30 and 100 mm~l/day.~ In the ab- 
sence of disease, the body can maintain short-term potas- 
sium balance with intakes as high as 10 mmovkg body 
weight.IL Most of the potassium is excreted in the urine. 
Thus, it is not surprising that hyperkalemia is typical in 
subjects with renal insufficiency. Accordingly, toxicity to 
high potassium intakes from the diet and/or supplements 
is a typical feature of subjects with renal insufficiency. 
It should be noted that renal insufficiency represents 
one important endpoint of hypertension. Many hyperten- 
sive subjects may have undiagnosed renal insufficiency. 
Hypertensive subjects on potassium-sparing diuretics 
represent another high-risk group for hyperkalemia, which 
can have fatal consequences from cardiac complications. 
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Therefore, it would be unfavorable to recommend potas- 
sium supplements for all hypertensive subjects or to pro- 
mote potassium supplements on a population scale, since 
a major percentage of patients show renal impairment. 
Potassium balance is influenced mainly by potassium 
intake and potassium excretion. Intake is basically a mat- 
ter of dietary choices. The potassium content of food may 
vary widely; however, milk, h i t s ,  grain products, veg- 
etables, and even some meats represent good sources. 
The ratio of dietary sodium to potassium should be taken 
into account. Food processing can profoundly affect this 
ratio. For example, raw potatoes have a low sodiundpotas- 
sium ratio, whereas potato chips have a very high ratio. 
Legumes, vegetables, fruits, and grains generally have a 
low ratio. Amainly vegetarian diet provides larger amounts 
of potassium. It has been suggested that the rather high 
potassium content of vegetarian diets may be partly re- 
sponsible for the beneficial blood pressure effects ob- 
served in vegetarians.I2 
The recently published Dietary Approaches to Stop 
Hypertension (DASH) trialI3 compared the effect of a typi- 
cal US.  diet (low in fruits and vegetables) with a diet that 
was high in fruits and vegetables and, consequently, higher 
in potassium. The consecutive blood pressure effects were 
up to 5.5 mm Hg systolic and 3.0 mm Hg diastolic. The 
DASH study does not permit us to identify any single 
nutrient responsible for this significant decline in blood 
pressure but, rather, an overall dietary pattern. Evidence 
suggests, however, that increased potassium intake may 
have been of considerable importance. The consumption 
of a diet rich in fruits and vegetables is in line with the 
current Dietary Guidelines for Americans and has been 
associated with lower rates of chronic disease. It is also a 
safe and realistic approach to increase potassium intake. 
In conclusion, potassium seems to have antihyper- 
tensive effects, but no single mechanism has been identi- 
fied. Because potassium's effects on blood pressure may 
be related to its complex interaction with several nutrients 
and substances, no single treatment strategy is success- 
ful for all subjects. The blood pressure-lowering effects 
of potassium may be not experienced by all subjects. Blood 
pressure should not, however, be the only endpoint for 
the recommendation of a high-potassium diet. Potassium 
may have other health effects in the cardiovascular sys- 
tem and may even play a direct or indirect role in carcino- 
gene~is .~J~  For the prevention and/or the nonpharmaco- 
logic therapy of hypertension, potassium from dietary 
sources (i.e., a diet rich in vegetables and fruits) should be 
encouraged rather than potassium supplements. Finally, 
it should be remembered that the control and prevention 
of hypertension start in the normotensive state and that 
no single healing electrolyte or nutrient seems to exist." 
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